# EDGAR Filing Document

**Accession Number:** 0001680367
**File Stem:** 0001193125-25-159387
**Filing Date:** 2025-7
**Character Count:** 5122
**Document Hash:** 424b4ee3fdb4e1d0c45e28e15e6f1f92
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-159387.hdr.sgml**: 20250715

**ACCESSION NUMBER**: 0001193125-25-159387

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250710

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250715

**DATE AS OF CHANGE**: 20250715

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Shattuck Labs, Inc.
- **CENTRAL INDEX KEY:** 0001680367
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 812575858
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39593
- **FILM NUMBER:** 251125130

**BUSINESS ADDRESS:**
- **STREET 1:** 500 W. 5TH STREET
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78701
- **BUSINESS PHONE:** 512-900-4690

**MAIL ADDRESS:**
- **STREET 1:** 500 W. 5TH STREET
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78701

?xml version='1.0' encoding='ASCII'? 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, DC 20549

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d)

#### of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): July 10, 2025

## Shattuck Labs, Inc.

#### (Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-39593** | **81-2575858** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(Commission**<br> **File Number)** | **(I.R.S. Employer**<br> **Identification Number)** |

---

#### 500 W. 5th Street, Suite 1200

#### Austin, TX 78701

#### (Address of principal executive offices, including zip code)
(512) 900-4690

#### (Registrant's telephone number, including area code)

#### Not Applicable

#### (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

#### Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br> **Symbol(s)** | **Name of each exchange**<br> **on which registered** |
| Common Stock, par value $0.0001 per share | STTK | The Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

#### Item 5.07. Submission of Matters to a Vote of Security Holders.
On Thursday, July 10, 2025, Shattuck Labs, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting"). As of the close of business on May 14, 2025, the record date for the Annual Meeting, there were 47,903,215 shares of common stock entitled to vote at the meeting. At the Annual Meeting, each of the Company's director nominees was elected and the other proposal voted on was approved. The final voting results are set forth below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Votes**<br> **For** | **Votes**<br> **Withheld** | **Broker**<br> **Non-Votes** |
|  **Proposal 1. Election of Class II Director Nominees** | **Proposal 1. Election of Class II Director Nominees** |  |  |  |
| • Neil Gibson, Ph.D. | • Neil Gibson, Ph.D. | 29632587 | 2367630 | 9026584 |
| • George Golumbeski, Ph.D. | • George Golumbeski, Ph.D. | 30303315 | 1696902 | 9026584 |
| • Kate Sasser, Ph.D. | • Kate Sasser, Ph.D. | 30351437 | 1648780 | 9026584 |
|  | **Votes**<br> **For** | **Votes**<br> **Against** | **Abstentions** | **Broker**<br> **Non-Votes** |
|  **Proposal 2. Ratification of KPMG LLP as Independent Auditor** | 41016269 | 5482 | 5050 | 0 |

---

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Shattuck Labs, Inc.** | **Shattuck Labs, Inc.** |
| Date: July 15, 2025 | By: | /s/ Dr. Taylor Schreiber |
|  |  | Dr. Taylor Schreiber |
|  |  | *Chief Executive Officer*<br> *(principal executive officer)* |

---